Accepted at 5:08 p.m. Mar, 04, 2024 by Ahmed7
Author: Ahmed7
Related Note: 1497200375971
Rationale for change

more commonly used in the deck

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::07_Immunosuppressants #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::01_Immunosuppressants::*Azathioprine #AK_Step1_v12::#Physeo::09_Pharm::01_Immunology::05_Azathioprine_&_6_MP #AK_Step1_v12::#UWorld::COMLEX::26758 #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Other::^EXPN #AK_Other::Only_Step_1 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#UWorld::Step::18704 #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::01_Antimetabolites::Extra #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::02_Azathioprine,_6-mercaptopurine,_Mycophenolate_Mofetil::zanki_extra #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Purine_Synthesis_Inhibitors::Azathioprine #AK_Step2_v12::#SketchyIM::07_Rheumatology::07_Systemic_Diseases::02_Systemic_Lupus_Erythematosus_SOAP #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::04_Azathioprine/6-MP #AK_Step1_v12::#B&B::15_MSK::03_Pathology::07_Muscle_Disorders::Extra